These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32039466)

  • 21. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy.
    Loverro G; Di Naro E; Caringella AM; De Robertis AL; Loconsole D; Chironna M
    Sex Transm Infect; 2016 Feb; 92(1):67-9. PubMed ID: 26203116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Human papillomavirus nonavalent vaccine. Update 2017].
    Bosch FX; Moreno D; Redondo E; Torné A
    Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of Cancer Development and Human Papilloma Virus Infection in Patients After Organ Transplantation.
    Suwalska A; Smolarczyk K; Kosieradzki M; Fiedor P
    Transplant Proc; 2020 Sep; 52(7):1982-1984. PubMed ID: 32474002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
    Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
    Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F
    Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anogenital malignancies in women after renal transplantation over 40 years in a single center.
    Meeuwis KA; Melchers WJ; Bouten H; van de Kerkhof PC; Hinten F; Quint WG; Massuger LF; Hoitsma AJ; van Rossum MM; de Hullu JA
    Transplantation; 2012 May; 93(9):914-22. PubMed ID: 22377788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
    Luxembourg A; Moeller E
    Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
    Moss JL; Reiter PL; Brewer NT
    Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of HPV-associated anogenital cancers.
    Wakeham K; Kavanagh K
    Curr Oncol Rep; 2014 Sep; 16(9):402. PubMed ID: 25118645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus, cancer and vaccination.
    Heard I
    Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus, human immunodeficiency virus and immunosuppression.
    Denny LA; Franceschi S; de Sanjosé S; Heard I; Moscicki AB; Palefsky J
    Vaccine; 2012 Nov; 30 Suppl 5():F168-74. PubMed ID: 23199960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of anogenital warts and cancer.
    Franco EL
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):597-623. PubMed ID: 8869948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
    Monsonego J
    Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.